Table 3.
Baseline characteristics of patients grouped according to posttransplant first year BMD scores.
| Normal BMD(n = 153) | Abnormal BMD(n = 81) | P value | |
|---|---|---|---|
| Age mean (±SD) | 42.1 (±12.9) | 38.5 (±12.2) | 0.03 |
| Sex, F/M (n) | 57/96 | 31/50 | 0.07 |
| Disease (n) | Unknown: 69 Gn/Vasc: 26 DM: 17 Others: 41 |
Unknown: 34 Gn/Vasc: 18 DM: 8 Others: 21 |
0.12 |
| DM, n (%) | 19 (12.4%) | 6 (7.4%) | 0.09 |
| Vintage, (month) med (min-max) | 19 (0–242) | 22 (0–228) | 0.90 |
| CNI, n (%) | Tac: 131 (85.6%) CsA: 18 (11.7%) |
Tac: 52 (64.1%) CsA: 13 (16.0%) |
0.04 |
| mTORi, n (%) | Eve: 9 (5.8%) Sir: 10 (6.5%) |
Eve: 4 (4.9%) Sir: 6 (7.4%) |
0.31 |
| Steroid, mg mean (±SD) | 3525.7 (±1050.3) | 3460.9 (±808.3) | 0.94 |
| eGFR mean (±SD) | 74.3 (±25.0) | 75.6 (±24.5) | 0.12 |
| Ca, mmol/L mean (±SD) | 2.38 (±0.15) | 2.35 (±0.13) | 0.68 |
| P, mmol/L mean (±SD) | 1.03 (±0.19) | 1.00 (±0.16) | 0.08 |
| Mg, mmol/L mean (±SD) | 0.85 (±0.10) | 0.90 (±0.15) | 0.60 |
| 25-OH-D, nmol/L mean (±SD) | 80.6 (±28.2) | 81.1 (±29.4) | 0.65 |
| Pre Tx iPTH, ng/L med (min-max) | 600.2 (60.4–2853.2) | 612.0 (128.1–1981.8) | 0.95 |
| 1st year iPTH, ng/L med (min-max) | 64.3 (14.5–2249.7) | 71.4 (26.9–950.9) | 0.03 |
| LDL, mmol/L mean (±SD) | 2.72 (±0.85) | 2.68 (±0.93) | 0.22 |
| TG, mmol/L mean (±SD) | 1.64 (±0.87) | 1.67 (±0.94) | 0.43 |
| Cdx2 CC/CT/TT (%) | 65.4/28.7/5.9 | 55.6/34.6/9.8 | 0.04 |
| Fok1 AA/AG/GG (%) | 7.2/43.1/49.7 | 12.3/42.0/45.7 | 0.31 |
| Bsm1 CC/CT/TT (%) | 40.5/47.7/11.8 | 28.4/34.6/37.0 | 0.04 |
| Apa1 CC/CA/AA (%) | 25.5/43.8/30.7 | 16.0/33.3/50.7 | 0.17 |
| Taq1 AA/AG/GG (%) | 43.8/45.7/10.5 | 30.8/34.6/34.6 | 0.10 |